- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Agilent Unveils New BioTek Cytation 9 Cell Imaging Multimode Reader
The latest addition to Agilent's Cytation portfolio combines advanced microplate reading and high-content cell imaging capabilities.
Apr. 2, 2026 at 6:35am
Got story updates? Submit your updates here. ›
Agilent Technologies has announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the company's Cytation portfolio. The Cytation 9 combines multimode microplate reading and high-content cell imaging in a single platform, helping laboratories streamline workflows while maintaining flexibility across diverse applications in fields like pharmaceutical and biotechnology research.
Why it matters
The Cytation 9 is designed to support more rigorous research demands, including faster, higher-throughput capabilities and adaptable tools for advanced cell-based models used in disease and drug discovery research. This latest innovation builds on over a decade of Cytation technology and aims to help researchers move from samples to insights faster.
The details
The Cytation 9 features expanded imaging capabilities along with advanced hybrid microplate detection technologies, including inverted fluorescence microscopy, upright imaging, and a multimode microplate reader module in a single instrument. This allows laboratories running both cell-based and biochemical assays to streamline workflows while maintaining flexibility across diverse applications.
- Agilent first introduced the BioTek Cytation portfolio in 2013.
- The Cytation 9 is the newest addition to the Cytation product line.
The players
Agilent Technologies, Inc.
A global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help customers bring great science to life.
Xavier Amouretti
Vice President, BioTek and Seahorse Business Unit Leader at Agilent.
What they’re saying
“For over a decade, Agilent's Cytation imagers have been used to automate tedious manual microscopy work and complex image analysis tasks. Cytation 9 is designed around the same principles, with a broader application range and twice the imaging speed. This comes from direct feedback from thousands of Cytation users. We believe Cytation 9 will help accelerate the next wave of discoveries in cell biology and drug development.”
— Xavier Amouretti, Vice President, BioTek and Seahorse Business Unit Leader
What’s next
Agilent plans to showcase the new BioTek Cytation 9 at upcoming industry events and conferences, providing researchers and scientists the opportunity to experience the instrument's capabilities firsthand.
The takeaway
The launch of the Cytation 9 underscores Agilent's commitment to delivering innovative solutions that empower researchers to accelerate scientific discoveries, particularly in the fields of cell biology and drug development. This latest addition to the Cytation portfolio aims to help laboratories streamline workflows and maintain flexibility across a wide range of applications.
